Late-stage RSV vaccine trials show ‘exciting promise,’ some scientists say

Home » Top Stories » Late-stage RSV vaccine trials show ‘exciting promise,’ some scientists say

A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling “exciting” promise in late-stage trials.

Categories:

Related Posts

FDA clears the way for additional bivalent boosters for certain vulnerable individuals
The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for
Repeated gunshots fired on live TV as ex-lawmaker shot by assassins
Atiq Ahmed, a former lawmaker in India's parliament, convicted of kidnapping, was shot dead along
US warns Russia not to touch American nuclear technology at Ukrainian nuclear plant
The US has sensitive nuclear technology at a nuclear power plant inside Ukraine and is